Logo image of PDX

PIMCO DYNAMIC INCOME STRAT (PDX) Stock Overview

USA - NYSE:PDX - US69346N1072

24.56 USD
+0.11 (+0.45%)
Last: 9/23/2025, 8:04:01 PM
Fundamental Rating

2

Overall PDX gets a fundamental rating of 2 out of 10. We evaluated PDX against 0 industry peers in the Unkown industry. PDX has a bad profitability rating. Also its financial health evaluation is rather negative. PDX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

PDX had positive earnings in the past year.
PDX had a negative operating cash flow in the past year.
PDX had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: PDX reported negative operating cash flow in multiple years.
PDX Yearly Net Income VS EBIT VS OCF VS FCFPDX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -500M -1B

1.2 Ratios

The last Return On Invested Capital (2.90%) for PDX is above the 3 year average (1.63%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 14.79%
ROE 20.32%
ROIC 2.9%
ROA(3y)16.82%
ROA(5y)0.55%
ROE(3y)21.29%
ROE(5y)-0.37%
ROIC(3y)1.63%
ROIC(5y)2.06%
PDX Yearly ROA, ROE, ROICPDX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

In the last couple of years the Profit Margin of PDX has grown nicely.
PDX's Operating Margin has been stable in the last couple of years.
PDX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 65.88%
PM (TTM) 280%
GM 64.71%
OM growth 3Y-4.01%
OM growth 5Y1.34%
PM growth 3Y-22.66%
PM growth 5Y41.45%
GM growth 3Y-3.34%
GM growth 5Y1.41%
PDX Yearly Profit, Operating, Gross MarginsPDX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 500 -500 1K -1K

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, PDX has more shares outstanding
Compared to 5 years ago, PDX has more shares outstanding
PDX has a worse debt/assets ratio than last year.
PDX Yearly Shares OutstandingPDX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
PDX Yearly Total Debt VS Total AssetsPDX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

PDX has an Altman-Z score of 1.68. This is a bad value and indicates that PDX is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 0.30 indicates that PDX is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 1.68
ROIC/WACCN/A
WACCN/A
PDX Yearly LT Debt VS Equity VS FCFPDX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

2.3 Liquidity

A Current Ratio of 0.03 indicates that PDX may have some problems paying its short term obligations.
PDX has a Quick Ratio of 0.03. This is a bad value and indicates that PDX is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
PDX Yearly Current Assets VS Current LiabilitesPDX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for PDX have decreased by -3.98% in the last year.
The Earnings Per Share has been growing by 71.60% on average over the past years. This is a very strong growth
Looking at the last year, PDX shows a very strong growth in Revenue. The Revenue has grown by 115.65%.
PDX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.56% yearly.
EPS 1Y (TTM)-3.98%
EPS 3Y5.61%
EPS 5Y71.6%
EPS Q2Q%-47.98%
Revenue 1Y (TTM)115.65%
Revenue growth 3Y36.87%
Revenue growth 5Y21.56%
Sales Q2Q%150%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PDX Yearly Revenue VS EstimatesPDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

PDX is valuated cheaply with a Price/Earnings ratio of 4.63.
When comparing the Price/Earnings ratio of PDX to the average of the S&P500 Index (27.41), we can say PDX is valued rather cheaply.
Industry RankSector Rank
PE 4.63
Fwd PE N/A
PDX Price Earnings VS Forward Price EarningsPDX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PDX Per share dataPDX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.06
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.36%, PDX is a good candidate for dividend investing.
PDX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 7.36%

5.2 History

PDX has been paying a dividend for over 5 years, so it has already some track record.
PDX has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years3
PDX Yearly Dividends per sharePDX Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

25.63% of the earnings are spent on dividend by PDX. This is a low number and sustainable payout ratio.
DP25.63%
EPS Next 2YN/A
EPS Next 3YN/A
PDX Yearly Income VS Free CF VS DividendPDX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 -500M -1B
PDX Dividend Payout.PDX Dividend Payout, showing the Payout Ratio.PDX Dividend Payout.PayoutRetained Earnings

More info and screens

PIMCO DYNAMIC INCOME STRAT

NYSE:PDX (9/23/2025, 8:04:01 PM)

24.56

+0.11 (+0.45%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)09-05 2025-09-05
Earnings (Next)03-06 2026-03-06
Inst Owners51.41%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner Change49.57%
Market Cap1.10B
AnalystsN/A
Price TargetN/A
Short Float %0.05%
Short Ratio0.28
Dividend
Industry RankSector Rank
Dividend Yield 7.36%
Yearly Dividend1.14
Dividend Growth(5Y)N/A
DP25.63%
Div Incr Years1
Div Non Decr Years3
Ex-Date09-12 2025-09-12 (0.1334)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 4.63
Fwd PE N/A
P/S 12.92
P/FCF N/A
P/OCF N/A
P/B 0.94
P/tB 0.94
EV/EBITDA N/A
EPS(TTM)5.31
EY21.62%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-6.6
FCFYN/A
OCF(TTM)-6.6
OCFYN/A
SpS1.9
BVpS26.19
TBVpS26.19
PEG (NY)N/A
PEG (5Y)0.06
Profitability
Industry RankSector Rank
ROA 14.79%
ROE 20.32%
ROCE 4.77%
ROIC 2.9%
ROICexc 2.9%
ROICexgc 2.9%
OM 65.88%
PM (TTM) 280%
GM 64.71%
FCFM N/A
ROA(3y)16.82%
ROA(5y)0.55%
ROE(3y)21.29%
ROE(5y)-0.37%
ROIC(3y)1.63%
ROIC(5y)2.06%
ROICexc(3y)1.64%
ROICexc(5y)2.07%
ROICexgc(3y)1.65%
ROICexgc(5y)2.11%
ROCE(3y)2.56%
ROCE(5y)2.98%
ROICexcg growth 3Y6.79%
ROICexcg growth 5Y21.51%
ROICexc growth 3Y9.28%
ROICexc growth 5Y21.73%
OM growth 3Y-4.01%
OM growth 5Y1.34%
PM growth 3Y-22.66%
PM growth 5Y41.45%
GM growth 3Y-3.34%
GM growth 5Y1.41%
F-Score4
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 4.75
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z 1.68
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.98%
EPS 3Y5.61%
EPS 5Y71.6%
EPS Q2Q%-47.98%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)115.65%
Revenue growth 3Y36.87%
Revenue growth 5Y21.56%
Sales Q2Q%150%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y230.97%
EBIT growth 3Y31.38%
EBIT growth 5Y23.19%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-323.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-323.65%
OCF growth 3YN/A
OCF growth 5YN/A